Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
2
×
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
2
×
detroit top stories
eli lilly
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
2
×
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
2
×
texas top stories
wisconsin blog main
wisconsin top stories
abiraterone
ac immune
acorda therapeutics
aduro biotech
agenus
alder biopharmaceutical
aldeyra therapeutics
aleksandra rizo
alexion pharmaceuticals
allergan
alzheimer's disease
american academy of neurology
What
companies
drug
2
×
therapies
year
2
×
alzheimer’s
approval
arguments
big
bio
class
commercialized
competitors
decades
different
drugs
fail
fda
gene
increases
latest
make
meeting
migraine
neuro
new
oral
pharmaceutical
plan
potential
prescription
price
prices
raise
roundup
start
typically
won
Language
Current search:
drug
×
biotech
×
year
×
" texas blog main "
×
" detroit blog main "
×
" raleigh-durham blog main "
×
@xconomy.com
5 years ago
At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More